Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,291,647
+$12,334,611 QoQ
Shares Held
1,778,032
+183.9% QoQ
Ownership
2.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 161 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. PHAT ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in PHAT

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,291,647 1,778,032
2026-03-31 $6,957,036 626,196
2025-12-31 $6,504,026 392,045
2025-09-30 $1,789,415 152,032
2025-06-30 $1,846,323 192,526
2025-03-31 $1,177,969 187,874
2024-12-31 $3,347,566 412,262
2024-09-30 $7,850,715 434,221
2024-06-30 $4,298,025 417,284
2024-03-31 $2,202,290 207,372
2023-12-31 $1,919,225 210,211
2023-09-30 $1,436,244 138,500
2023-06-30 $2,214,845 154,668
2023-03-31 $347,581 48,681
2022-12-31 $830,414 74,012
2022-09-30 $635,349 57,342
2022-06-30 $442,019 52,372
2022-03-31 $385,665 28,337
2021-12-31 $671,081 34,117
2021-09-30 $229,932 7,163
2020-12-31 $1,464,271 44,078